ADVERTISEMENT

Neogen Chemicals Q4 Review - Custom Synthesis Offers Strong Visibility Ahead: ICICI Direct

Neogen Chemicals Q4 Review - Custom Synthesis Offers Strong Visibility Ahead: ICICI Direct

<div class="paragraphs"><p>Chemical solutions in glass flask sits inside a lab. (Source: pxhere)</p></div>
Chemical solutions in glass flask sits inside a lab. (Source: pxhere)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Neogen Chemicals Ltd.'s topline broadly stayed in line with our estimates while the bottomline was higher due to lower taxes.

Reported revenue growth of 69.2% YoY to Rs 156.8 crore, led by higher growth from both segments such as organic chemical (up 38% YoY) and inorganic chemical segment (up 176% YoY).

Neogen Chemicals' gross margins declined 100 basis points YoY to ~42.5% while Ebitda margin fell 300 bps YoY to 17%, due to higher other operating cost.

Ebitda was up 44% YoY to Rs 26.6 crore. Profit after tax increased 68% YoY to Rs 15.6 crore.

Click on the attachment to read the full report:

ICICI Direct Neogen Chemicals Q4FY22 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.